CFTR and respiratory tract infectious disorder: Therefore, the future holds promise, especially with the development of genetic therapies and further advanced CFTR modulators that restoration of CFTR activity can aid in attenuating respiratory infections in CF, but a majority of the adult pwCF will remain infected with different multidrug resistant airway bacteria and will need additional therapies they can tolerate to improve their quality and quantity of life.